0 CHECKOUT

Cisco Systems - 2014 Q4: Weak Results - Still no growth

  • ID: 2977356
  • July 2014
  • 45 Pages
  • Indigo Equity Research
1 of 3

This report provides a detailed financial analysis and review of the company. The report includes: SWOT analysis, investment thesis, fundamental & DCF Valuation; as well as a review of: significant recent events, operations analysis, ten year financial analysis, business model, strategy, major M&A activity, industry overview and latest Q results.

Independent, buy-side, fundamental, financial analysis.

Note: Product cover images may vary from those shown
2 of 3

Investment Thesis & SWOT Analysis

News Flow - Significant Recent Events

Company Analysis
Key Industry Themes & Drivers for 2014
Company Overview
Management, Executive Compensation & Board
Strategy
Key Acquisitions & History
Key Divisions
Other Products
Business Model - Last 12 Months
SWOT Analysis
Additional Investment Issues
Income Tax Issues

Key Fundamental Drivers

Historical Financial Results - Quarterly Analysis since 2
Profit & Loss Summary
Revenue Analysis by Division
Deferred Revenues
Revenue & Gross Profit by Product
Revenue & Gross Profit by Region
Expenses Analysis
Free Cash Flow Analysis
Balance Sheet Analysis
Return Analysis
Unusual Items

Valuation
Fundamental Valuation of Cisco Systems
DCF Valuation & Reality Check
Historical Valuation Multiples
Consensus Forecasts & Valuation Multiples

Industry Analysis
IT & Networking Industry Key Trends
IT & Networking Industry Key Trends (details)
Networking Industry - History & Overview

Tables of Historical Financial Results
Quarterly & Annual Financial Accounts
Revenue & Product Order Data
Revenue & Gross Profit by Region
Revenue & Gross Profit by Product

Explanations, Legal and Important Information

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown

PURCHASING OPTIONS

HAVE A QUESTION?

EMAIL US VIEW FAQs

RELATED PRODUCTS from Db

Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.